Royalty Pharma EVP Research & Investments Marshall Urist sells 4,126 shares for $238,812.88

By Public Technologies
  • Marshall Urist, EVP, Research & Investments, sold 4,126 Royalty Pharma Class A ordinary shares on Sept. 28, 2026.
  • Sale priced at USD 57.88 per share.
  • Direct holdings fell to 4,126 shares.
  • Indirect holdings include 19,020 shares held by an IRA.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Royalty Pharma plc published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001838139-26-000026), on September 30, 2026, and is solely responsible for the information contained therein.

Capital Com is an execution-only service provider. The present material must be regarded as marketing communication and should not be interpreted as investment research or investment advice. Any opinion that may be provided on this page does not constitute a recommendation by Capital Com or its agents. We do not make any representations or warranty on the accuracy or completeness of the information that is provided on this page. If you rely on the information on this page, then you do so entirely at your own risk